Botox for migraines on NHS step closer
THE use of Botox to treat chronic migraine on the NHS moved a step nearer today. Health watchdog the National Institute for Health and Clinical Excellence (NICE) has published final draft guidance which recommends the anti-wrinkle jab for the condition. NICE is advising the NHS whether the benefits of Botox, known chemically as botulinum toxin type A and manufactured by Allergan, for chronic migraine are value for money. Chronic migraines involve having headaches for at least 15 days a month over three months, eight of which are migraines.